Thumb that up ^
- Forums
- ASX - By Stock
- NEU
- Ann: FDA approves Daybue - the first treatment for Rett syndrome
NEU
neuren pharmaceuticals limited
Add to My Watchlist
1.90%
!
$15.45

Ann: FDA approves Daybue - the first treatment for Rett syndrome, page-3
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
$15.45 |
Change
-0.300(1.90%) |
Mkt cap ! $1.951B |
Open | High | Low | Value | Volume |
$15.80 | $15.80 | $15.40 | $2.421M | 155.0K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
3 | 145 | $15.44 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$15.46 | 153 | 6 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
2 | 347 | 15.430 |
5 | 619 | 15.420 |
4 | 1125 | 15.410 |
10 | 15417 | 15.400 |
4 | 1044 | 15.390 |
Price($) | Vol. | No. |
---|---|---|
15.460 | 299 | 6 |
15.470 | 295 | 3 |
15.480 | 1045 | 3 |
15.490 | 349 | 2 |
15.500 | 382 | 2 |
Last trade - 10.50am 23/07/2025 (20 minute delay) ? |
Featured News
NEU (ASX) Chart |